Prevent Cancer Foundation® awards seven new research grants
POUR DIFFUSION IMMÉDIATE
Kyra Meister
703-836-1746
kyra.meister@preventcancer.org
Alexandria, Va. – The Prevent Cancer Foundation is pleased to announce funding for seven scientists who are researching cancer prevention and early detection. Each scientist has been awarded $100,000 for two years. Areas of focus include the blood, breast, cervix, colon, liver and lung. Listed below are the 2022 research grantees. Cliquez ici pour des informations plus détaillées sur leurs projets.
Bénéficiaire: Sarah Bernhardt, Ph.D.
Titre du projet: Vitamin D as a Preventive Agent for Young Women’s Breast Cancer
Prix nommé : Stohlman Family Grant in memory of Richard Stohlman and Margaret Weigand
Position: Postdoctoral Fellow
Institution: Oregon Health and Science University, Portland, OR
Cancer prevention strategies targeted to time periods of increased breast cancer risk have the potential to increase treatment efficacy while reducing side effects of long-term treatments. Dr. Bernhardt proposes to test the efficacy of vitamin D, an agent with anti-cancer actions, for breast cancer prevention.
Bénéficiaire: Francesca Gany, M.D.
Titre du projet: FITx3
Prix nommé : Des jeux géniaux réalisés rapidement
Position: Chief, Immigrant Health and Cancer Disparities Service
Institution: Memorial Sloan Kettering Cancer Center, New York, NY
Black people are 40% more likely to die of colorectal cancer (CRC) than most other groups; however, screening improves survival. This project aims to increase CRC screening in the Black communities with low screening rates by adapting methods used to increase Black voter turnout and applying them to enable accessible fecal immunochemical testing (FIT) screening. FIT is a highly effective and potentially more acceptable screening method than colonoscopy.
Bénéficiaire: Ju Youn Kim, Ph.D.
Titre du projet: To Investigate the Roles of PIDDosome in NASH and HCC Development
Prix nommé : Programme de prévention du cancer des familles du Congrès
Position: Staff Research Associate
Institution: The Regents of the University of California, San Diego, CA
With a diet-induced obese mouse model, Dr. Kim will address the role of capase-2 in liver steatosis, the first metabolic dysregulation found in patients with non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) development. This study will provide insight into the early detection of NASH and HCC progression.
Bénéficiaire: Suzanne Miller, Ph.D.
Titre du projet: Feasibility of Text Messaging to Reduce Urban Cervical Cancer Disparities
Prix nommé : Fondation caritative Marcia et Frank Carlucci
Position: Professor
Institution: The Research Institute of Fox Chase Cancer Center
Cervical cancer is preventable, but underserved women in the U.S. have lower rates of recommended follow-up after an abnormal test result. This study will assess the feasibility, acceptability and usability of a text message-based tailored counseling intervention to increase follow-up care.
Bénéficiaire: Gary Schwartz, Ph.D., M.P.H., Ph.D.
Titre du projet: Testing Radon Communication Methods: Clinical Trial of a Smartphone App
Prix nommé : Prix Richard C. Devereaux du jeune chercheur exceptionnel
Position: Professor and Founding Chair Department of Population Health
Institutions: University of North Dakota, Grand Forks, ND
Exposure to radon gas at home is the second largest cause of lung cancer (after smoking). Dr. Schwartz developed a 21st century approach to radon education—a smartphone app. His research compares information delivered via the radon app versus printed brochures, with potential wide implementation of the educational tool.
Bénéficiaire: Tomotaka Ugai, Ph.D.
Titre du projet: Immune Characteristics of Early-Onset and Later-Onset Colorectal Cancers
Prix nommé : La Fondation caritative de la famille Shure
Position: Postdoctoral Fellow
Institutions: Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health, Boston, MA
This research study will provide the scientific foundation to explore possible influences of anti-tumor immunity on early-onset colorectal cancer and ultimately generate strategies to harness the immune system for prevention and early detection, with significant impact on clinical practice.
Bénéficiaire: Lisa Yee, M.D.
Titre du projet: White Button Mushrooms and Breast Cancer Prevention
Prix nommé : Des jeux géniaux réalisés rapidement
Position: Professor, Vice Chair of Research, Department of Surgery
Institutions: Beckman Research Institute of the City of Hope, Duarte, CA
White button mushrooms (WBM) may reduce breast cancer risk. In a WBM trial with obese women at high risk of breast cancer, Dr. Yee will test blood and breast fat before and after WBM consumption for effects on immune cell and inflammation biomarkers. This study data will support future WBM breast cancer prevention trials.
###
About the Prevent Cancer Foundation®
The Prevent Cancer Foundation® is the only U.S. nonprofit organization focused solely on saving lives across all populations through cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated.
La Fondation se mobilise pour relever le défi de réduire les décès par cancer de 40% d'ici 2035. Pour y parvenir, nous nous engageons à investir $20 millions dans des technologies innovantes pour détecter le cancer à un stade précoce et faire progresser le dépistage multi-cancer, $10 millions pour étendre le dépistage du cancer et la vaccination. l'accès à des communautés médicalement mal desservies et $10 millions pour informer le public sur les options de dépistage et de vaccination.
Pour plus d'informations, s'il vous plaît visitez www.preventcancer.org.